Literature DB >> 21424585

Durable remission of leptomeningeal metastases from hormone-responsive prostate cancer.

Meng Zhang1, Ali Mahta, Ryan Y Kim, Serra Akar, Santosh Kesari.   

Abstract

Prostate cancer is rarely associated with leptomeningeal metastasis. An 87-year-old man with a history of prostate cancer presented with leptomeningeal metastasis. He received hormonal therapy with leuprolide. Subsequently, he achieved an impressive response, indicated by a constant fall in his PSA levels and by the stabilization of leptomeningeal disease and clinical improvement. Hormonal therapy may be effective in inducing remission in hormone-sensitive prostate cancer with leptomeningeal metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424585     DOI: 10.1007/s12032-011-9906-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  15 in total

Review 1.  Leptomeningeal metastases.

Authors:  Santosh Kesari; Tracy T Batchelor
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

2.  Diagnosis and outcome measures in trials for neoplastic meningitis: a review of the literature and clinical experience.

Authors:  M J Glantz; B C Walters
Journal:  Neurosurg Focus       Date:  1998-06-15       Impact factor: 4.047

3.  Spinal leptomeningeal metastases from prostate cancer.

Authors:  R Deinsberger; R Regatschnig; B Kaiser; H C Bankl
Journal:  Acta Neurochir (Wien)       Date:  2005-11-30       Impact factor: 2.216

Review 4.  Neurologic complications of prostate cancer.

Authors:  Ramsis Benjamin
Journal:  Am Fam Physician       Date:  2002-05-01       Impact factor: 3.292

Review 5.  Leptomeningeal metastases: a review of evaluation and treatment.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: an effect of improved systemic therapy?

Authors:  C Lin; S Turner; H Gurney; A Peduto
Journal:  J Med Imaging Radiat Oncol       Date:  2008-08       Impact factor: 1.735

7.  Metastatic prostate carcinoma to the intradural extramedullary spinal compartment. Case report.

Authors:  Stephen J Hentschel; Ehud Mendel; Sanjay Singh; Laurence D Rhines
Journal:  J Neurosurg       Date:  2004-04       Impact factor: 5.115

8.  Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review.

Authors:  Lawrence A Cone; Kamran Koochek; Helene A Henager; Richard Fausel; Radhika Gade-Andavolu; Barbara E Potts; Lela M Jennings
Journal:  Surg Neurol       Date:  2006-04

9.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

Review 10.  Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer.

Authors:  Rajni Sethi; Nicholas Sanfilippo
Journal:  Clin Interv Aging       Date:  2009-06-09       Impact factor: 4.458

View more
  1 in total

1.  Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy.

Authors:  Neil Chevli; Amarinthia E Curtis; Suzanne Powell; Pamela New; E Brian Butler; Bin S Teh
Journal:  Adv Radiat Oncol       Date:  2021-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.